The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Corvus Pulls Plug On Mupadolimab COVID-19 Program With Candidate Now Prioritized In Oncology
Corvus Pharmaceuticals Inc (NASDAQ:CRVS) has discontinued its Phase 3 study of mupadolimab for COVID-19 due to positive trends exhibited by COVID-19…
HC Wainwright & Co. Maintains Buy on Corvus Pharmaceuticals, Lowers Price Target to $6
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy and lowers the price target from $9.5 to $6.
Corvus Says With Discontinuation Of Phase 3 Mupadolimab Study, Now Expects FY21 Net Cash Used In Operating Activities $35M-$37M, Down From Prior Expectation Of $46M-$48M
As of June 30, 2021, Corvus had cash, cash equivalents and marketable securities totaling approximately $66.5 million. This compared to cash, cash equivalents and marketable securities of $44.3 million as of December 31,
Corvus Pharmaceuticals Discontinues Phase 3 Study Of Mupadolimab (Anti-CD73) For COVID-19, Citing Vaccine Effectiveness In Reducing Hospitalizations
Mupadolimab Phase 1/1b oncology clinical trial continues, with a focus on leveraging B cell activation and enhancement of anti-viral antibodies in an expansion cohort for patients with HPV+ (human papilloma virus) head
Stocks That Hit 52-Week Lows On Thursday
During the morning session on Thursday, 152 stocks hit new 52-week lows.
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
Corvus Pharmaceuticals Granted U.S. Patent Titled ‘Methods of treating cancer’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11040040.PN.&OS=PN/11040040&RS=PN/11040040